Filed Pursuant to 424(b)(4)
Registration Nos. 333-231609 and 333-231679
$180,000,000

4.00% Convertible Senior Notes Due 2024
We are offering $150,000,000 principal amount of our 4.00% Convertible Senior Notes due 2024. The notes will bear interest at a rate of 4.00% per year, payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2019. The notes will mature on June 1, 2024, unless earlier converted, redeemed or repurchased.
Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding March 1, 2024 only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ending on June 30, 2019 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined below) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (3) if we call any or all of the notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their notes at any time, regardless of the foregoing circumstances. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, as described in this prospectus.
The conversion rate will initially be 44.8179 shares of common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $22.3125 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if we deliver a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with such a corporate event or notice of redemption, as the case may be.
We may not redeem the notes prior to June 1, 2022. We may redeem for cash all or any portion of the notes, at our option, on or after June 1, 2022 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the notes.
If we undergo a fundamental change (as defined in this prospectus), holders may require us to repurchase for cash all or any portion of their notes at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The notes will be our general unsecured obligations and will rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the notes, equal in right of payment with all of our liabilities that are not so subordinated, effectively junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness, and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.
Concurrently with this offering, we are offering 24,000,000 shares of our common stock (or 27,600,000 shares of common stock if the underwriters in that offering exercise in full their over-allotment option to purchase additional shares), in an underwritten offering pursuant to a separate prospectus. The closing of this offering is not conditioned upon the closing of the concurrent public offering, and the closing of the concurrent public offering is not conditioned upon the closing of this offering. This prospectus is not an offer to sell or a solicitation of an offer to buy any securities being offered in the concurrent offering of common stock. A portion of the common stock offered in the concurrent common stock offering may be delivered to a depository, which will then issue Swedish Depository Receipts (“SDRs”) to relevant non-U.S. person purchasers of our common stock that have requested receipt of SDRs. The number of SDRs that may be delivered will be limited due to Swedish legal restrictions.
We do not intend to apply to list the notes on any securities exchange or any automated dealer quotation system. Our common stock is listed on the New York Stock Exchange under the symbol “VNE” and SDRs representing shares of our common stock are listed on Nasdaq Stockholm under the trading symbol “VNE SDB”. The last reported sale price of our common stock on the New York Stock Exchange on May 22, 2019 was $17.96 per share. The last reported sale price of our SDRs on Nasdaq Stockholm on May 22, 2019 was SEK 176.1 per SDR.
Investing in the notes involves a high degree of risk. See “Risk Factors” beginning on page 9.
| | | | | | | | |
| | Per Note | | | Total | |
Public offering price (1) | | | 100 | % | | $ | 180,000,000 | |
Underwriting discounts and commissions | | | 2.75 | % | | $ | 4,950,000 | |
Proceeds, before expenses, to us | | | 97.25 | % | | $ | 175,050,000 | |
(1) | Plus accrued interest, if any, from May 28, 2019. |
We have granted the underwriters the right to purchase, exercisable within a 30 day period, up to an additional $27,000,000 principal amount of notes, solely to cover over-allotments.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
Delivery of the notes is expected to be made on or about May 28, 2019.
| | | | |
MORGAN STANLEY | |
NORDEA | | | SEB | |
The date of this prospectus is May 22, 2019.